Archive for June 4, 2021

FDA Approves First Treatment for Patients with Plasminogen Deficiency, a Rare Genetic Disorder

Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tvmh) for the treatment of patients with plasminogen deficiency type 1, also referred to as…

Coronavirus (COVID-19) Update: June 4, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On June 1, the…

FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014

Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight…